Year: 2007
Type: article
Abstract: In the past 6 years, several randomized controlledtrials have been conducted to test the impact ofbehavioral and pharmacological interventions onrates of development of type 2 diabetes in high-risk groups (1–7). The studies have demonstrated that it is possible to reduce the number of people who develop diabetes by 25–62 % over 3- to 6-year time frames. As a result, discussions on mitigating the growing public health problem of type 2 diabetes have expanded from a rela-tively narrow focus on disease treatment to a broader focus on disease prevention. Ultimately, the broader focus is relevant to prevention and early treatment, both aimed at stabilization or reversal of an otherwise progressive disease process. Optimal strategies for disease modifica-tion at the stages of pre-diabetes and early diabetes remain to be defined. However, existing information is sufficient to begin to sort out the relative effectiveness of interven-tions and to make some recommendations for clinical
Source: Diabetes
DOI: 10.2337/db07-0140
Author: Thomas A. Buchanan
Institution: University of Southern California
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2113246605
